|
Aigner A
MicroRNAs (miRNAs) in cancer invasion and metastasis: therapeutic
approaches based on metastasis-related miRNAs.
J Mol Med (Berl) 2011; 89(5): 445-457
ISSN 0946-2716
Fromberg
A, Gutsch D, Schulze D, Vollbracht C, Weiss G, Czubayko F,
Aigner A
Ascorbate exerts anti-proliferative effects through cell cycle
inhibition and sensitizes tumor cells towards cytostatic drugs.
Cancer Chemother Pharmacol 2011; 67(5): 1157-1166
ISSN 0344-5704
Gunther M, Lipka J, Malek A, Gutsch D,
Kreyling W, Aigner A
Polyethylenimines for RNAi-mediated gene targeting in vivo and siRNA
delivery to the lung.
Eur J Pharm Biopharm 2011; 77(3): 438-449
ISSN 0939-6411
Hendruschk S, Wiedemuth R, Aigner A, Topfer K,
Cartellieri M, Martin D, Kirsch M, Ikonomidou C, Schackert G, Temme A
RNA interference targeting survivin exerts antitumoral effects in vitro
and in established glioma xenografts in vivo.
Neuro Oncol 2011; 13(10): e1074-1089
ISSN 1522-8517
Höbel
S, Loos A, Appelhans D, Schwarz S, Seidel J, Voit B, Aigner A
Maltose- and maltotriose-modified, hyperbranched poly(ethylene imine)s
(OM-PEIs): Physicochemical and biological properties of DNA and siRNA
complexes.
J Control Release 2011; 149(2): 146-158
ISSN 0168-3659
Ibrahim AF, Weirauch U, Thomas
M, Grunweller A, Hartmann RK, Aigner
A
MicroRNA replacement therapy for miR-145 and miR-33a is efficacious in
a model of colon carcinoma.
Cancer Res 2011; 71(15): 5214-5224
ISSN 0008-5472
Kretzing S, Abraham G, Seiwert B, Ungemach
FR, Krugel U, Regenthal R
Dose-dependent emetic effects of the Amaryllidaceous alkaloid lycorine
in beagle dogs.
Toxicon 2011; 57(1): 117-124
ISSN 0041-0101
Kretzing S, Abraham G, Seiwert B, Ungemach
FR, Krugel U, Teichert J, Regenthal
R
In vivo assessment of antiemetic drugs and mechanism of
lycorine-induced nausea and emesis.
Arch Toxicol 2011; 85(12): 1565-1573
ISSN 0340-5761
Schulze D, Plohmann P, Hobel S, Aigner A
Anti-tumor effects of fibroblast growth factor-binding protein (FGF-BP)
knockdown in colon carcinoma.
Mol Cancer 2011; 00: 00
ISSN 1476-4598
|